Cargando…
Optimization of a small molecule inhibitor of secondary nucleation in α-synuclein aggregation
Parkinson’s disease is characterised by the deposition in the brain of amyloid aggregates of α-synuclein. The surfaces of these amyloid aggregates can catalyse the formation of new aggregates, giving rise to a positive feedback mechanism responsible for the rapid proliferation of α-synuclein deposit...
Autores principales: | Staats, Roxine, Brotzakis, Z. Faidon, Chia, Sean, Horne, Robert I., Vendruscolo, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493395/ https://www.ncbi.nlm.nih.gov/pubmed/37701726 http://dx.doi.org/10.3389/fmolb.2023.1155753 |
Ejemplares similares
-
Structure-Based
Discovery of Small-Molecule Inhibitors
of the Autocatalytic Proliferation of α-Synuclein Aggregates
por: Chia, Sean, et al.
Publicado: (2022) -
Exploration and
Exploitation Approaches Based on Generative
Machine Learning to Identify Potent Small Molecule Inhibitors of α-Synuclein
Secondary Nucleation
por: Horne, Robert I., et al.
Publicado: (2023) -
Secondary Processes
Dominate the Quiescent, Spontaneous
Aggregation of α-Synuclein at Physiological pH with Sodium
Salts
por: Horne, Robert I., et al.
Publicado: (2023) -
Surface-Catalyzed Secondary Nucleation Dominates the Generation of Toxic IAPP Aggregates
por: Rodriguez Camargo, Diana C., et al.
Publicado: (2021) -
Screening of small molecules using the inhibition of oligomer formation in α-synuclein aggregation as a selection parameter
por: Staats, Roxine, et al.
Publicado: (2020)